A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

Withdrawn before enrolling · Phase 3 · Has a placebo group

Conditions studied: Overweight, Obesity

In brief

This study is being done to find out how well a medicine called CagriSema helps people with overweight or obesity lose weight. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance using a computer program, so neither participants nor study staff will know which treatment is given. The study will last for about one year.

Key facts

Study ID
NCT07357766
Run by
Novo Nordisk A/S
People needed
0
Starts
2026-06-22
Expected to finish
2028-01-17
Last updated by the study team
2026-07-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.